To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 27 November 2023
Document: FOI 23/858 - attachment (PDF)

Found: FOI 23/227 We are writing to you due to the update to the Valproate Pregnancy Prevention Program published


Non-Departmental Publication (News and Communications)
Medicines and Healthcare products Regulatory Agency

Feb. 20 2024

Source Page: Letters and medicine recalls sent to healthcare professionals in January 2024
Document: Oral valproate-containing medicines: Restriction of indication for male and female patients aged under 55 years; use revised educational materials (PDF)

Found: Letters and medicine recalls sent to healthcare professionals in January 2024


Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 29 August 2022
Document: FOI 22/888 - attachment (PDF)

Found: Other factors could include a history of rash on other antiepileptic drugs, and age <13 years.


Select Committee
Correspondence from Patient Safety Commissioner to the Chair on Sodium valproate 16.11.23

Correspondence Nov. 29 2023

Committee: Health and Social Care Committee (Department: Department of Health and Social Care)

Found: Correspondence from Patient Safety Commissioner to the Chair on Sodium valproate 16.11.23 Correspondence


Non-Departmental Publication (News and Communications)
Medicines and Healthcare products Regulatory Agency

Nov. 28 2023

Source Page: MHRA instructs health organisations to prepare now for new measures to reduce ongoing serious harms of valproate
Document: MHRA instructs health organisations to prepare now for new measures to reduce ongoing serious harms of valproate (webpage)

Found: MHRA instructs health organisations to prepare now for new measures to reduce ongoing serious harms of valproate


Non-Departmental Publication (Statistics)
Medicines and Healthcare products Regulatory Agency

Nov. 28 2023

Source Page: Valproate: review of safety data and expert advice on management of risks
Document: Valproate: review of safety data and expert advice on management of risks (PDF)

Found: Valproate: review of safety data and expert advice on management of risks


Commons Chamber
Economic Growth - Tue 14 Nov 2023
HM Treasury

Mentions:
1: Henry Smith (Con - Crawley) a hereditary peer—in the other place. - Speech Link
2: Selaine Saxby (Con - North Devon) Anti-business rhetoric from Lib Dems is so damaging in a constituency such as mine. - Speech Link
3: Cat Smith (Lab - Lancaster and Fleetwood) Sodium valproate continues to be prescribed today, and for some women it will be the only medication - Speech Link
4: Laura Trott (Con - Sevenoaks) Member for Lancaster and Fleetwood is in her place, but I note her remarks on sodium valproate and will - Speech Link


Non-Departmental Publication (Transparency)
Commission on Human Medicines

Jul. 19 2023

Source Page: Human Medicines Regulations 2012 Advisory Bodies Annual Report 2022
Document: Human Medicines Regulations 2012 Advisory Bodies Annual Report 2022 (Accessible) (PDF)

Found: SAFETY OF MARKETED MEDICINES Valproate – Use during pregnancy; impaired fertility in males 16


Non-Departmental Publication (Transparency)
Commission on Human Medicines

Jul. 19 2023

Source Page: Human Medicines Regulations 2012 Advisory Bodies Annual Report 2022
Document: Human Medicines Regulations 2012 Advisory Bodies Annual Report 2022 (PDF)

Found: SAFETY OF MARKETED MEDICINES Valproate – Use during pregnancy; impaired fertility in males 16


Scottish Parliament Debate - Committee
Patient Safety Commissioner for Scotland Bill: Stage 1 - Tue 07 Feb 2023

Mentions:
1: None It has been a massive struggle—certainly for valproate, as well as for other areas—to get access to information - Speech Link
2: None One of the things that we are looking for, in Valproate Scotland, is implementation of the other Cumberlege - Speech Link
3: None pregnancy prevention plan and that they are on effective contraception.Since 2018, in England, we have - Speech Link
4: None guiding those of us in public bodies and others to new areas—in other words, the commissioner should - Speech Link